Veterinary Surgical Instruments Market Size & Share 2026-2035

Veterinary Surgical Instruments Market Size

The veterinary surgical instruments market was valued at USD 1.6 billion in 2025 to USD 3.1 billion by 2035, reflecting a 6.8% CAGR. The market covers reusable and single-use instruments used in companion-animal, livestock, and exotic-animal procedures, including sutures and staplers, forceps, scalpels, retractors, trocar-cannula access systems, and electrosurgical devices.

Demand is moving beyond replacement of basic stainless-steel sets. U.S. pet-industry expenditure reached USD 158 billion in 2024, including USD 41.0 billion for veterinary care and product sales ^{[1]American Pet Products Association, americanpetproducts.org}. That spending base supports both routine procedural throughput and investment in equipment that changes the surgical offering of a practice. The clinical shift is most visible in minimally invasive surgery: veterinary surgeons report use of laparoscopy and thoracoscopy across procedures such as gonadectomy, gastropexy, liver biopsy, and cholecystectomy, while advanced soft-tissue MIS training is formalized through the ACVS fellowship pathway ^{[2]DVM360, dvm360.com}.

Instrument demand therefore divides into two purchasing logics. High-volume sterilization and soft-tissue work sustain recurring consumption of wound-closure and access products, whereas orthopedic, dental, and MIS procedures require higher-value sets, energy devices, and specialized visualization-compatible instruments. Insurance and corporate practice ownership can amplify both pathways by making expensive procedures more financially accessible and by centralizing procurement standards. North American pet insurance reached 7.03 million insured pets and USD 4.74 billion in gross written premium in 2024.

Key Drivers

Increasing animal healthcare expenditure in developed nations

Higher veterinary expenditure changes the mix of instruments purchased, not merely the volume. In the United States, the scale of veterinary-care spending provides practices with a larger revenue base for surgical upgrades. In Europe, pet ownership is also deeply embedded: FEDIAF reports 278 million pets, excluding aquaria, across 41 European countries ^{[3]FEDIAF, europeanpetfood.org}. As owners authorize orthopedic repair, oncology-related excision, or advanced soft-tissue procedures, hospitals need durable specialty sets and consumables rather than only basic spay-neuter kits.

Rising awareness about various animal health conditions

Greater recognition of dental disease, orthopedic injury, reproductive conditions, and soft-tissue disorders broadens the surgical case mix. The effect on procurement is procedure-specific: early diagnosis of oral disease supports dental elevators and extraction instruments; management of cruciate injury supports osteotomy and arthroscopy systems; and broader use of laparoscopic soft-tissue procedures increases demand for ports, graspers, and vessel-sealing tools. Published veterinary MIS literature documents that the technology is extending into increasingly complex abdominal procedures.

Escalating demand for pet health insurance

Insurance reduces the immediate cost hurdle for interventions that require specialty instrumentation. NAPHIA reported USD 3.07 billion in claims paid in North America in 2024, up 23.6% year over year ^{[4]North American Pet Health Insurance Association, naphia.org}. Claims growth does not identify surgical spending alone, but it indicates that insured owners are using coverage at greater scale. For suppliers, the relevant consequence is higher procedure acceptance and more predictable use of consumable sutures, electrodes, stapler reloads, and single-use access devices.

Growth in the number of veterinary practitioners in developed nations

The U.S. had 130,415 active veterinarians at the end of 2024, versus 127,131 a year earlier. Additional clinicians expand the installed base of practices capable of performing surgery, but specialty-instrument uptake depends on training, mentoring, and referral economics. The U.S. workforce outlook anticipates growth in companion-animal veterinarians through 2030, supported by expanded training capacity. That concentration is favorable to surgical categories tied to small-animal specialty care.

Key Restraints

Lack of skilled veterinary professionals in developing economies

A surgical instrument is productive only when clinical skill, anesthesia support, sterilization capability, and postoperative care are available together. In lower-density veterinary markets, practitioners and advanced surgical capacity tend to be concentrated in cities, restricting adoption of MIS, orthopedic, and microsurgical instruments in rural livestock areas. Even in the United States, AVMA identifies continuing difficulty in attracting veterinarians to rural practice. The implication for manufacturers is that distribution alone will not unlock demand; training and service models are needed to turn equipment availability into procedure volume.

High cost of veterinary surgeries

Procedure affordability limits adoption across uninsured companion-animal care and smallholder livestock practice. Insurance growth eases that constraint for a minority of animals in mature markets, but it does not eliminate price sensitivity. AVMA reported that household veterinary spending declined in 2024 despite a growing pet population. Practices consequently balance the clinical benefits of premium, single-use, or energy-based products against owner budgets and the reprocessing economics of reusable instruments.

Veterinary Surgical Instruments Market Segment Analysis

By Product

Sutures and staplers hold the largest product share at 24.4% and are forecast to grow at 6.3% CAGR. Their breadth reflects a non-substitutable role in wound closure across soft-tissue, sterilization, dental, and orthopedic work. Stapling can add value in selected gastrointestinal and thoracic procedures, while routine suture demand remains exposed to price competition. Medtronic offers veterinary open stapling systems and reload configurations, illustrating how a human-device platform can be adapted to veterinary tissue-management needs.

Forceps account for 14.5% of 2025 revenue and grow at 6.9%. They remain foundational to clamping, tissue handling, and needle control, but premiumization is concentrated in specialty variants, precision tips, and durable jaw inserts. Integra's Miltex veterinary portfolio spans general, microsurgical, and ophthalmic instrument configurations ^{[5]Integra LifeSciences, products.integralife.com}, demonstrating the value of catalog depth where practices require procedure-specific sets.

Scalpels represent 8.5% share and a 7.2% CAGR. Disposable formats can reduce sterile-processing steps in high-throughput clinics, whereas reusable handles remain cost-effective where reprocessing infrastructure is reliable. Surgical scissors account for 7.5% share and grow 6.5%; energy-based dissection may displace part of the cutting-and-hemostasis role of conventional scissors in advanced cases rather than eliminate demand for precision cold-steel instruments.

Hooks and retractors hold 6.0% share and grow 7.5%, supported by increasingly complex deep-tissue and orthopedic procedures. Trocars and cannulas account for 9.2% and have a 7.9% CAGR because they are direct enablers of laparoscopic access. Their demand is tied to the number of ports per case, so growth in MIS increases both system sales and recurring single-use or replacement demand.

Electro-surgery instruments are the second-largest product category at 18.5% and the fastest growing at 8.2% CAGR. Their appeal is functional: they combine cutting and hemostasis, and bipolar or vessel-sealing designs are especially relevant when surgeons seek controlled energy delivery. Medtronic identifies LigaSure veterinary vessel-sealing devices as part of its animal-health portfolio ^{[6]Medtronic Animal Health, medtronic.com}, while B. Braun Vet Care supplies reusable and single-use laparoscopic instruments for minimally invasive veterinary surgery. Other products, including bone, dental, ophthalmic, suction, and irrigation tools, represent 11.4% share and a 5.8% CAGR; this grouping contains valuable niches but lacks one common purchasing driver.

By Animal Type

Companion animals represent 61.4% of the market and grow at 6.9% CAGR. Dogs, cats, horses, and other companion animals generate demand ranging from high-volume sterilization to specialty orthopedics and dental care. The category benefits most directly from insurance, practice consolidation, and owner willingness to fund advanced care. Jorgensen Laboratories maintains a veterinary-specific offering across instruments and equine equipment, illustrating the separate needs of small-animal and equine settings.

Livestock animals account for 32.1% and grow at the highest animal-type CAGR, 7.8%. Cattle, sheep and goats, swine, and poultry require durable instruments suited to field conditions, obstetrics, trauma, and production-animal workflows. Growth reflects the expanding value placed on food-animal health, but affordability and practitioner availability temper the conversion of livestock populations into advanced-surgery demand. Exotic and zoo animals represent 6.5% share and a 7.4% CAGR; anatomical diversity and low procedure volumes favor precision and customized sets over standardized scale.

By Application

Soft-tissue surgery leads applications with 34.2% share and a 6.8% CAGR. It draws on multiple product categories at once, including closure materials, access systems, graspers, and energy devices. Sterilization surgery accounts for 18.4% and grows 7.5%; its high procedure volume makes it important for basic sets and consumables, while laparoscopic sterilization creates an upgrade path where clinical capability is available.

Dental surgery represents 19.1% share and a 7.2% CAGR. The category requires dedicated extraction and periodontal instruments and benefits from more systematic diagnosis of oral disease. Vimian completed the acquisition of iM3 in October 2024, adding a veterinary dental equipment business with sales across more than 40 countries. Orthopedic surgery has the highest application CAGR at 7.9% on a 15.5% share, reflecting the capital intensity of osteotomy, fracture, and arthroscopy procedures. Arthrex Vet Systems supplies veterinary orthopedic and arthroscopy solutions, aligning its portfolio with this premium segment. Ophthalmic surgery accounts for 6.8% share and 6.5% CAGR; its use of microsurgical instruments supports value density but is limited by specialist capacity. Other applications hold 6.0% share and grow 6.1%.

By End Use

Veterinary hospitals hold 48.7% share and grow 7.6%. Their case complexity, specialist staffing, and capital budgets support broad instrument portfolios and formal reprocessing programs. Veterinary clinics represent 38.7% share and the fastest end-use CAGR at 8.1%, as general practices expand surgical capability to retain procedures that would previously have been referred. Academic and research institutes account for 8.1% and grow 7.2%; they require training sets and specialized microsurgical tools. Other end users, including welfare organizations and public veterinary services, represent 4.5% and grow 6.5%, with demand weighted toward dependable high-volume instruments.

Veterinary Surgical Instruments Market Regional Analysis

North America

North America holds 40.40% of the 2025 market. The region is forecast to grow at 7.2% CAGR, with market value rising from USD 658.68 million in 2025 to USD 1,201.47 million in 2035. The United States accounts for 91.2% of regional demand and Canada 8.8%. U.S. veterinarian numbers, pet-care expenditure, and insurance penetration create the deepest installed base for specialty instruments. Canada's 7.5% CAGR reflects scope for specialty-care and insurance adoption from a smaller base.

Europe

Europe represents 28.10% share and a 7.5% CAGR. Germany, the UK, France, Italy, Spain, and the Netherlands combine a substantial companion-animal base with established veterinary distribution. Germany recorded 33.9 million pets in 2024 ^{[7]ZZF/IVH, zzf.de}. In the UK, RCVS recorded 37,801 veterinary surgeons in its 2024 reporting year ^{[8]Royal College of Veterinary Surgeons, rcvs.org.uk}. These mature markets favor quality, traceability, and specialty capability; their growth is more likely to come from procedure mix and standardized procurement than from basic instrument penetration alone.

Asia Pacific

Asia Pacific holds 20.50% share and is forecast to grow fastest at 8.5% CAGR. China and India offer expanding companion-animal and livestock demand but face uneven access to specialized surgical training. Japan and Australia provide more mature premium-care environments, while South Korea adds a dense urban companion-animal opportunity. The regional strategy differs by country: advanced energy and MIS systems fit developed referral networks, whereas distributor service, training, and durable general-surgery products are more relevant to infrastructure-building markets.

Latin America

Latin America accounts for 7.20% share and a 7.7% CAGR. Brazil, Mexico, and Argentina combine urban companion-animal care with large production-animal sectors. This mix creates demand for both premium small-animal instruments and robust livestock tools, but economic volatility and owner affordability can delay adoption of high-cost surgical modalities. Suppliers that offer serviceable reusable sets alongside selective specialty products are better positioned than those relying solely on capital-intensive systems.

Middle East and Africa

The Middle East and Africa represent 3.80% of the market and grow at 6.8% CAGR. South Africa, Saudi Arabia, and the UAE are the authorized focal markets. Urban clinic development and companion-animal care support demand in Gulf markets, while livestock health underpins a broader requirement for field-ready instruments. The key bottleneck remains the density of trained personnel and equipped facilities, making education and post-sale support commercially material.

Veterinary Surgical Instruments Market Share & Competitive Landscape

Competition combines diversified medical-technology companies with veterinary-focused specialists. Scale matters in energy devices, stapling, manufacturing, and global distribution, while veterinary-specific suppliers compete through anatomy-specific configurations, direct practice relationships, and service. The authorized company scope is profiled below.

Arthrex - Arthrex Vet Systems focuses on veterinary orthopedic, arthroscopy, and surgical solutions, positioning the company in high-value companion-animal and equine procedures.

Avante Animal Health (Avante Health Solutions) - Avante Animal Health serves veterinary providers with equipment and instrument-access options oriented toward budget-conscious practices and high-throughput settings.

B. Braun Vet Care - B. Braun Vet Care markets Aesculap-branded surgical, minimally invasive, and electrosurgical products for veterinary use.

BMT Medizintechnik - BMT Medizintechnik participates in precision instruments and sterilization-related solutions relevant to veterinary and laboratory settings.

Ethicon (Johnson & Johnson) - Ethicon brings wound-closure and surgical-device heritage to the veterinary channel, with orthopedic technology also represented through the wider Johnson & Johnson MedTech portfolio.

Eickemeyer - Eickemeyer is a veterinary-focused supplier with broad surgical-instrument and practice-equipment coverage.

GerMedUSA - GerMedUSA addresses general veterinary instrument demand with stainless-steel surgical products.

Integra LifeSciences - Integra's Miltex range covers veterinary surgical instruments, including general, ophthalmic, and microsurgical configurations.

Jorgensen Laboratories - Jorgensen Laboratories supplies veterinary instruments, equine equipment, and related practice products through an established specialist channel.

Medtronic - Medtronic's animal-health offering includes stapling and vessel-sealing platforms, giving it a strong position in energy-based and advanced soft-tissue surgery.

Neogen Corporation - Neogen operates across animal safety and food safety, with veterinary disposables and animal-health products complementing its broader portfolio.

Sklar Surgical Instruments - Sklar Surgical Instruments supplies general and specialty surgical instruments to human and veterinary care settings.

STERIS - STERIS expanded its surgical-instrument offering through the 2023 acquisition of BD surgical instrumentation assets, including V. Mueller, Snowden-Pencer, and Genesis brands.

Smiths Medical - Smiths Medical's infusion, vascular-access, and perioperative products remain relevant to surgical support; ICU Medical completed its acquisition of the business in January 2022.

Surgical Holdings - Surgical Holdings competes through manufacture, repair, and lifecycle management of reusable surgical instruments.

Vimian Group - Vimian's MedTech strategy gained veterinary dental capability through its iM3 acquisition, giving the group a direct position in a specialized instrument category.

World Precision Instruments - World Precision Instruments serves precision and microsurgical requirements in biomedical research and laboratory-animal surgery.

The competitive advantage is increasingly determined by fit with the customer's operating model. Referral hospitals value advanced performance, integration, and reprocessing reliability; general clinics value training and workflow simplicity; livestock settings require durable products and distribution reach. Acquisitions such as Vimian-iM3 and STERIS-BD demonstrate that specialized capability and instrument breadth can be built through portfolio transactions rather than organic product development alone.

Recent Industry Developments

Vimian Group completes iM3 acquisition (October 2024)

Vimian completed the acquisition of iM3 Dental Limited and iM3 Pty Ltd on October 1, 2024. The transaction added a veterinary dental equipment specialist to Vimian's MedTech business and extended its distribution reach across more than 40 countries.

STERIS completes acquisition of BD surgical instrumentation assets (August 2023)

STERIS completed its acquisition of BD surgical instrumentation, laparoscopic instrumentation, and sterilization-container assets on August 2, 2023. The transaction brought the V. Mueller, Snowden-Pencer, and Genesis portfolios into STERIS.

Neogen partners with US Equestrian (August 2024)

Neogen announced an official partnership with US Equestrian in August 2024, linking its equine animal-health offering with education and care resources for the equestrian community.